Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians

Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians

Abstract Introduction Some patients with rheumatoid arthritis (RA) using tumor necrosis factor inhibitors (TNFi) experience inefficacy or lack of tolerability and hence switch to another TNFi (cycling) or to a therapy with another mode of action (switching). This study examined patient characteristi...

Full description

Bibliographic Details
Main Authors: Emma Sullivan, Jim Kershaw, Stuart Blackburn, Jeannie Choi, Jeffrey R. Curtis, Susan Boklage
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-04-01
Series:Rheumatology and Therapy
Subjects:
Biologic disease-modifying antirheumatic drugs
Cycling
Rheumatoid arthritis
Switching
Tumor necrosis factor inhibitors
Online Access:https://doi.org/10.1007/s40744-020-00203-w

Internet

https://doi.org/10.1007/s40744-020-00203-w

Similar Items